Takeda issues notice relating to stock acquisition rights for directors

Takeda has said that that the amount to be paid in exchange for stock acquisition rights to be granted to members of its board of directors were decided in accordance with the resolution of its board of directors meeting held on June 25th 2009.

In a statement, the organisation explained that the allotment date of stock acquisition rights is July 10th 2009 and that the total number of stock acquisition rights allotted is 669.

This equates to 100 shares per one stock acquisition right.

A total of five people – all of whom are company directors – will have the rights allotted to them and each will pay 273,500 yen (1,841 pounds) in exchange for one right.

This is the equivalent of 2,735 yen per share.

“On the allotment date, the company shall make a consensual offset between the remuneration credits held by the director toward the company and the right to demand payment of the amount to be paid in for stock acquisition rights,” Takeda said.

Earlier this month, Takeda announced the advancement of clinical trials for CBP501, a therapy intended for the management of non-small cell lung cancer.